The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis

By sjmartinez • February 2, 2024

Acevedo A, Jones AE, Danna BT, Turner R, Montales KP, Benincá C, Reue K, Shirihai OS, Stiles L, Wallace M, Wang Y, Bertholet AM, Divakaruni AS. The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis. J Biol Chem. 2024 Jan 30:105702. doi: 10.1016/j.jbc.2024.105702. Epub ahead of print. PMID: 38301896.

Tags: branched-chain amino acids, BT2, cardiometabolic disease, chemical uncoupling, Endocrinology, mitochondria, Publications, ROS production

Obesity and Cardio-Metabolic Health in Kidney Disease: Implications for Kidney Health, Risk Stratification, and Management

Mathew RO, Hong A, Narasaki Y, Fung E, Cheung D, Han J, Durstenfeld MS, Hsue PY, Rhee CM. Obesity and Cardio-Metabolic Health in Kidney Disease:[...]

Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism

Brass EP. Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism. N Engl J Med. 2026 Sep 10;395(10):1035. doi: 10.1056/NEJMc2609133. PMID: 42715571.

The metabolic road from α-cells to β-cells

Hamba Y, Choi J, Yoshihara E. The metabolic road from α-cells to β-cells. Nat Chem Biol. 2026 Sep 9. doi: 10.1038/s41589-026-02302-1. Epub ahead of print.[...]